CyageniCyagen
HomeAI Assistant
Toolbox
Databases
Resources
About Us
AI Tools
RNA Splicer
ASO Designer
Pathogenicity Predictor
Bioinfo Tools
Sequence Viewer
Mutation Direct
Antibody Discovery
Target Insights
Computational Analysis
Databases
Gene Database
Disease Database
Model Database
Mutation Database
Learn
Learning Center
Explore
iCyagen
Cyagen
OriCellTM
AbSeekTM
Contact
Contact Us
EN
中文
Spinal Muscular Atrophy, Type I (SMA1)
Alias:
Werdnig-Hoffmann Disease
|
Sma1
|
Hmn Proximal Type I
|
Hereditary Motor Neuropathy Proximal Type I
|
Progressive Muscular Atrophy of Infancy
|
Infantile Muscular Atrophy
|
Spinal Muscular Atrophy 1
|
Spinal Muscular Atrophy-1
|
Werdnig-Hoffman Disease
|
Sma Type 1
|
Sma Type I
|
Sma I
|
Sma-I
|
Survival Motor Neuron Spinal Muscular Atrophy
|
Proximal Hereditary Motor Neuropathy Type I
|
Severe Infantile Spinal Muscular Atrophy
|
Proximal Spinal Muscular Atrophy Type 1
|
Infantile-Onset Spinal Muscular Atrophy
|
Infantile Spinal Muscular Atrophy
|
Spinal Muscular Atrophy, Type 1
|
Spinal Muscular Atrophy Type I
|
Muscular Atrophy, Infantile
|
Sma, Infantile Acute Form
|
Werdnig Hoffmann Disease
|
Sma Infantile Acute Form
|
Smni
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Spinal muscular atrophy type I is a severe neuromuscular disorder caused by mutations in the SMN1 gene, leading to degeneration of motor neurons in the spinal cord and brain stem. Symptoms typically appear before 6 months of age and include progressive muscle weakness, poor muscle tone, feeding difficulties, and respiratory problems. Patients with SMA type I never achieve the ability to sit without support. The disease is inherited in an autosomal recessive manner and can be diagnosed through genetic testing. SMA type I is characterized by symmetrical muscle weakness and atrophy, affecting voluntary muscles, with the most severe form being Werdnig Hoffmann disease. If left untreated, SMA type I is the most common genetic cause of infant death.
Related ID:
MALACARDS: SPN393
|
OMIM: 253300
|
MESH: D014897
|
ICD11: 915903258
Basic Information
Inheritance
Age of Onset
Prevalence
Related Genes
Related Mouse Models
Reference
MALACARDS
AR
Autosomal recessive
Newborn
--
51
342
109
SPN393
Medical Symptom
Phenotype Information Associated with the Current Disease:
Categorization: Anatomical classification of the disease manifestations.
HPO Frequency/Orphanet Frequency: Indicates the probability of the manifestation occurring in the current disease, allowing sorting by probability.
HPO Source Accession: Links to HPO for detailed manifestation information.
Data Source: HPO, Orphanet
Gene & Mutation
Genes and Mutations Associated with the Current Disease:
Function: Primary biological roles of the genes.
Score: Indicates the strength of the association between the disease and the gene, with higher scores reflecting stronger associations.
Count: Number of mutations associated with the disease-gene pair. The number in parentheses represents the total data points linked to the same ClinVar ID. Clicking the number reveals mutation details.
Data Source: Clinvar
Related Drugs
Drugs Related to the Current Gene, Displaying CAS Number, Status and Phase.
Data Source: Clinical Trials
Related Mouse Models
Mouse Models Related to the Current Gene. Click on the model name to view detailed information.
Data Source: MGI, Cyagen
References Literature
Most Relevant Literature for the Current Gene, Filterable by Year, Article Type, and Sortable by Impact Factor.
Data Source: UniProt, PubMed
Cyagen
Home
Tools
Database
Resources
About Us
Email: icyagen-support@cyagen.com
Phone: +86 18620792549
Address: No.98, Xiangxue Road, Huangpu District, Guangzhou City
Follow us on social media
Contact us via LinkedIn
Link: https://www.linkedin.com/company/cyagen-biosciences
Copy
Contact us via YouTube
Link: https://www.youtube.com/@Cyagen
Copy
iCyagen
Copyright © 2024 Cyagen Biosciences. All Rights Reserved.
Privacy Policy
User Agreement
Back to top